Vitamin K2 can tackle neuroinflammation and degeneration, study finds

Published: 7-May-2024
Ingredients Cognitive

The study highlights how vitamin K2 supports healthy cognitive function through a reduction in gene expression associated with inflammation and degeneration in the brain

Andrea Fuso, PhD, a 15-year research collaborator with Gnosis by Lesaffre focusing on cognitive health, has expanded his area of study to include Vitamin K2 in neurological support, publishing a new study highlighting K2’s role in neurological protection. 

The study, published in Cells, identifies a link between supplemental K2 and neurodegeneration and neuroinflammation, pointing to K2’s potential role as a supplement for support of healthy brain and cognitive function.

 

Supporting neurological function with K2

In the new study1, Fuso, Associate Professor in Clinical Biochemistry and Molecular Biology, Department of Experimental Medicine, Sapienza University of Rome, examined K2 as menaquinone-7 (in a reduced form) along with K2 menaquinone-4 on a model of neuroblastoma cells to determine how forms of K2 affect the expression of genes involved in neurodegeneration and neuroinflammation.

Vitamin K2 administration was found to support neurological function by creating a favourable balance of activity, reducing the expression of genes associated with neurodegeneration (PSEN1 and BACE1) and neuroinflammation (IL-1β and IL-6), while simultaneously upregulating genes that protect against amyloid formation (ADAM10 and ADAM17).

Additionally, the team also profiled the DNA methylation patterns of the genes and discovered a correlation between hypermethylation and the downregulation of PSEN1, IL-1β, and IL-6.

This new mechanistic study supports earlier work discussing K2’s roles in Alzheimer’s via gut dysbiosis.[2]

Summarising his research, Dr Fuso commented: “Our earlier studies highlighted the role of B vitamins and SAMe as dietary factors connecting nutrition with the epigenetic modulation of brain disease. Now, we introduce research on a new compound crucial for cognition: Vitamin K2.”

“Our 15-year collaboration with Dr Fuso and his team has resulted in a growing body of evidence demonstrating how ingredients of natural origin [e.g., SAMe and vitamin K2 (as MK-7)] significantly impact the function of the brain and cognitive activity.” Says Jean-François Jeanne, Substantiation and Applications Manager at Gnosis by Lesaffre.

 

Reference

1 Fuso et al. “Amyloidogenic and Neuroinflammatory Molecular Pathways Are Contrasted Using Menaquinone

  • Companies:
  • Gnosis by Lesaffre
See more

You may also like

Ingredients

LifeinU BSCU1: embrace your health now and for the future

Read more
New biotics solutions are flooding the market to capitalise on the ever-changing immunity seeking consumer. However, one probiotic solution, LifeinU® BSCU1 from Gnosis by Lesaffre, has not only shown proven efficacy for immune support, but exciting new evidence confirms its protective role for immunity and beyond

Trending Articles

  1. The perfect pair: how vitamins K2 and D3 combine to support health and well-being Hydrogen and oxygen, Yin and Yang, Batman and Robin; the world is full of iconic duos that combine to become more than the sum of their parts. One relatively unknown yet equally powerful partnership is that of vitamins D3 and K2
  2. Degradation of vitamins, probiotics and other active ingredients caused by exposure to heat, water and sunlight Vitamins and probiotics (and other active ingredients) can be substantially affected by exposure to heat, water and/or sunlight
  3. Arla achieves certification for native milk protein Arla Foods Ingredients has received certification by the Non-GMO Project for its native milk protein MicelPure, a micellar casein isolate
  4. Vitamin K2 MK-7: healthy bone, healthy body There is growing recognition that vitamin K2 plays a crucial role in lifelong bone health, and that bone health may be just the first chapter in a developing K2 story, reports Jim Beakey, Marketing Director, Kappa Bioscience AS
  5. Grains of paradise can enhance mental wellbeing and sleep quality, new study shows Nektium's novel grains of paradise extract, Vanizem, has been clinically shown to improve mood and sleep quality without any sedative effects

Upcoming event

Bridge2Food Summit Europe

June 5-6 2024 | Summit | The Hague, Netherlands See all

You may also like

Ingredients

LifeinU BSCU1: embrace your health now and for the future

New biotics solutions are flooding the market to capitalise on the ever-changing immunity seeking consumer. However, one probiotic solution, LifeinU® BSCU1 from Gnosis by Lesaffre, has not only shown proven efficacy for immune support, but exciting new evidence confirms its protective role for immunity and beyond
Ingredients

SAMe holds promise for depression, studies find

Two novel studies have suggested S-Adenosylmethionine (SAMe) could be a beneficial monotherapy for patients with depression
Ingredients

SunWay Biotech and Gnosis by Lesaffre form alliance to launch MenaQ7 Metabolic

The novel product will be aimed at the lucrative vitamin K2 market
Ingredients

Vitamin K2 could be at the heart of a healthy lifestyle

Further evidence highlights the impact of essential nutrients on cardiovascular health, including potential $9.48B a year in healthcare cost savings
Ingredients

Gnosis vitamin K2 scientific advisory committee grows and holds first meeting

The inaugural meeting of the Gnosis K2SAC welcomed new members and focused on the exciting future for K2
Ingredients

Gnosis by Lesaffre launches MenaQ7 Protect

A collaboration between Gnosis and Probiotical creates the first private-label, ready-to-market, immune-support supplement featuring clinically validated MenaQ7 K2
Ingredients

New MenaQ7 K2 cardio study in kidney patients published

TReVasc-HDK Trial examined the efficacy of K2 supplementation in reducing vascular calcification progression in haemodialysis patients, offering new insights on appropriate dosing
Subscribe now